Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pill-induced liver disease.

Canadian family physician Medecin de famille canadien·2011
Same author

Management of acute alcoholic conditions.

Canadian family physician Medecin de famille canadien·2010
Same author

Protective drugs in alcoholism treatment.

Canadian family physician Medecin de famille canadien·2010
Same author

[Not Available].

Canadian family physician Medecin de famille canadien·2010
Same author

Review of the problems of hepatitis.

Canadian family physician Medecin de famille canadien·2010
Same author

Medical aspects of drug abuse.

Canadian family physician Medecin de famille canadien·2010
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

Alcoholic liver disease.

P Devenyi

    Canadian Family Physician Medecin De Famille Canadien
    |May 15, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Alcoholic liver disease, including fatty liver and alcoholic hepatitis, can progress to fibrosis and cirrhosis. Early intervention and cessation of alcohol intake are crucial for potential reversal and preventing severe liver damage.

    More Related Videos

    Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
    10:42

    Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

    Published on: May 13, 2016

    Related Experiment Videos

    Last Updated: Jun 13, 2026

    Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
    10:45

    Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

    Published on: May 25, 2017

    Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
    10:42

    Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

    Published on: May 13, 2016

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Internal Medicine

    Background:

    • Alcoholic liver disease (ALD) encompasses distinct pathological entities.
    • Fatty liver is the most frequent hepatic abnormality in individuals with alcohol use disorder.
    • ALD can progress through stages including fatty liver, alcoholic hepatitis, fibrosis, and cirrhosis.

    Purpose of the Study:

    • To present a general model for understanding the progression of alcoholic liver disease.
    • To highlight the reversible nature of early-stage ALD.
    • To elucidate the potential pathways leading to hepatic fibrosis and cirrhosis.

    Main Methods:

    • Review of established pathological entities within alcoholic liver disease.
    • Analysis of the natural history and progression of liver injury due to alcohol.
    • Conceptual modeling of disease progression based on clinical and pathological observations.

    Main Results:

    • Fatty liver, the most common hepatic abnormality in alcoholics, is often reversible.
    • Sustained fatty liver may lead to fibrosis.
    • Alcoholic hepatitis and subclinical necrosis can also result in hepatic fibrosis, which may regress or progress to cirrhosis.

    Conclusions:

    • Alcoholic liver disease follows a spectrum from reversible fatty liver to irreversible cirrhosis.
    • The progression to fibrosis and cirrhosis is dependent on continued alcohol-induced liver injury.
    • Understanding this disease model is critical for clinical management and patient outcomes.